# Med Research review links pan-cancer multi-omics to tumor recurrence and metastasis mechanisms

- Published: 2026-11-13 05:05 UTC
- Section: Life & Health › Medicine
- Tags: tumor recurrence, metastasis, pan-cancer analysis, multi-omics, single-cell omics, spatial omics, minimal residual disease, clonal selection, tumor microenvironment, precision oncology
- URL: https://realtech.media/news/rt-4529819ad9b6c6a5582c2fa0_med_research_review/

**A review in Med Research combines six omics layers into one mechanistic framework for recurrence and metastasis across cancer types.**

![Med Research review links pan-cancer multi-omics to tumor recurrence and metastasis mechanisms](https://realtech.media/media/2026/11/b9f87985dad1de2a.jpg)
*Nephron, Wikimedia Commons, CC BY-SA 3.0*

A review in Med Research (DOI 10.1002/mdr2.70098), announced by the International Society for Health Data Science on 10 November 2026, offers a mechanism-oriented pan-cancer view of tumor recurrence and metastasis. The authors, including Wenjun Meng and Weimin Li, integrate evidence from genomics, transcriptomics, proteomics, metabolomics, single-cell and spatial omics [1]. This is a literature review, not a new experiment or clinical trial.

The authors state that recurrence and metastasis remain the leading causes of treatment failure and cancer-related mortality [1]. According to the review, these processes arise from dynamic evolutionary interactions among genomic alterations, cellular plasticity and adaptation of the tumor microenvironment. Single-layer molecular analyses cannot fully explain such interactions [1].

The authors note that earlier reviews covered either pan-cancer metastasis or multi-omics technologies. A unified framework that links shared biological mechanisms across cancer types with multi-omics evidence and clinical translation was, in their words, still lacking [1].

## Shared evolutionary programs

The review does not describe individual technologies one by one. It examines how each omics layer adds complementary information about common evolutionary programs [1]. These include clonal selection, cell-state plasticity, immune and stromal remodeling, metabolic adaptation and treatment-induced evolution [1].

The authors also discuss how multi-omics integration can move from descriptive associations toward mechanistic understanding. They name three approaches: longitudinal sampling, spatial analysis and functional validation [1].

## Translational directions

The review outlines the potential of multi-omics for four clinical tasks [1]:

- recurrence-risk prediction;
- monitoring of minimal residual disease;
- identification of therapeutic vulnerabilities;
- development of perioperative intervention strategies.

By linking shared pan-cancer biological programs with clinically relevant applications, the paper offers a conceptual framework for understanding recurrence and metastasis. It also sets out directions for translating multi-omics findings into precision oncology [1]. The figure accompanying the announcement shows the cross-cancer sequence: primary-tumor ecosystem, clonal diversification and genomic instability, cell-state plasticity, microenvironmental selection and dissemination, then local recurrence and distant metastasis.

## Sources

1. [Med Research](https://doi.org/10.1002/mdr2.70098)
2. [EurekAlert](https://www.eurekalert.org/news-releases/1151403)

---

Source: RealTech, realtech.media — https://realtech.media/news/rt-4529819ad9b6c6a5582c2fa0_med_research_review/